Unassociated Document
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
___________________________________
 
FORM 8-K
 
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
 

 
Date of report (Date of earliest event reported):  December 26, 2009

CHINA SKY ONE MEDICAL, INC.
(Exact Name of Registrant as Specified in Charter)

Nevada
  
000-26059
  
87-0430322
(State or Other Jurisdiction
  
(Commission
  
(IRS Employer
of Incorporation)
  
File Number)
  
Identification No.)

Room 1706, Di Wang Building, No. 30 Gan Shui Road,
Nangang District, Harbin, People’s Republic of China 150001
(Address of Principal Executive Offices)

Registrant's telephone number, including area code:  86-451-53994073 (China)
 

(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 
o
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
 
o
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
     
  o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
     
  o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 
 
 
Item 3.02.
Unregistered Sales of Equity Securities.
 
As of December 26, 2009, China Sky One Medical, Inc. (the “Company”) issued an aggregate of 52,844 shares of it’s common stock (the “Shares”) to 11 recipients (the “Recipients”) under the Company’s 2006 Stock Incentive Plan.  The Shares were issued in consideration for services rendered by the Recipients to the Company, and were valued at a price of $23.50 per share, the last reported closing price of shares of the Company’s common stock on the Nasdaq Global Market as of the date of issuance.

The Company believes that the issuance of the Shares in these transactions is exempt from registration under the Securities Act of 1933, as amended, pursuant to Section 4(2), and/or Regulation D promulgated thereunder, as a transaction by an issuer not involving a public offering.

Item 5.02.
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
 
Reference is made to the disclosure set forth under Item 3.02 above, which disclosure is incorporated herein by reference.  Included among the Recipients are certain executive officers and directors of the Company, as follows:

Name
  
Title
  
Number of Shares
Liu Yan-qing
  
President, Chief Executive Officer and Chairman of the Board of Directors (principal executive officer)
  
18,687
Han Xiao-yan
  
Vice Chairman and Director
  
14,327
Hao Yu-bo
  
Chief Financial Officer, Secretary and Director (principal financial officer)
  
6,229
William Wei Lee
  
Independent Director
  
1,038
Zhao Jie
  
Independent Director
  
831
Song Chun-fang
  
Independent Director
  
831
Qian Xu-feng
  
Independent Director
  
831

The issuances were recommended by unanimous written consent of the Company’s Compensation Committee, and authorized by unanimous written consent of the Company’s Board of Directors, as of December 26, 2009.

Item 9.01.                      Financial Statements and Exhibits
 
(d)  
Exhibits.

The exhibits listed in the following Exhibit Index are filed as part of this Form 8-K.

Exhibit No.
  
Description
     
4.1
  
2006 Stock Incentive Plan – Incorporated by reference to the Company’s Definitive Information Statement on Schedule 14C, filed on July 6, 2006
 
 
 
 
 
SIGNATURE
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 
CHINA SKY ONE MEDICAL,  INC.
  
 
(Registrant)
  
       
Date: December 31, 2009 
By:
/s/ Liu Yan-qing  
    Liu Yan-qing  
    Chairman, Chief Executive Officer and President